Literature DB >> 27013615

Diffuse HIV-associated seborrheic dermatitis - a case series.

Amy K Forrestel1, Carrie L Kovarik2, Anisa Mosam3, Deepti Gupta4, Toby A Maurer5, Robert G Micheletti2.   

Abstract

Seborrheic dermatitis (SD) is reported to have distinct clinical and histologic presentations in patients with HIV infection. Here we present 20 cases to further define some of these unique characteristics. Common features include erythematous, scaly papules, and plaques involving areas beyond the typical seborrheic distribution; thick, greasy scale on the scalp; and an increased frequency of erythroderma. Histologically, there is widespread parakeratosis, spongiosis, and necrotic keratinocytes. Treatment is often difficult, requiring prolonged use of oral and topical antifungals and corticosteroids as well as antibiotics for bacterial superinfection. SD with these features represents a marker for HIV infection and can aid in early diagnosis.
© The Author(s) 2016.

Entities:  

Keywords:  AIDS; HIV; Seborrheic dermatitis; dermatology; human immunodeficiency virus

Mesh:

Substances:

Year:  2016        PMID: 27013615     DOI: 10.1177/0956462416641816

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  8 in total

Review 1.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

2.  Tanshinone Capsules Combined With Prednisone for Facial Seborrheic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Qiang Fu; Mengya Huang; Lei Tang; Qi Zheng; Fujun Huang; Xun Zhou; Shumei Wang
Journal:  Front Med (Lausanne)       Date:  2022-04-29

3.  Isolation of Malassezia spp. in HIV-positive patients with and without seborrheic dermatitis.

Authors:  Gabriela Moreno-Coutiño; Carlos D Sánchez-Cárdenas; Yesenia Bello-Hernández; Ramón Fernández-Martínez; Sara Arroyo-Escalante; Roberto Arenas
Journal:  An Bras Dermatol       Date:  2019-09-30       Impact factor: 1.896

4.  The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study.

Authors:  Elena Campione; Sara Mazzilli; Caterina Lanna; Terenzio Cosio; Vincenzo Palumbo; Gaia Cesaroni; Flavia Lozzi; Laura Diluvio; Luca Bianchi
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-16

5.  Altered serum elements, antioxidants, MDA, and immunoglobulins are associated with an increased risk of seborrheic dermatitis.

Authors:  Ishrat Jahan; Md Rabiul Islam; Md Reazul Islam; Rubaiya Ali; S M Matiur Rahman; Zabun Nahar; Abul Hasnat; Md Saiful Islam
Journal:  Heliyon       Date:  2021-03-28

6.  Facial Dermatoses in Patients With Blepharitis: a Cross-sectional Prospective Analysis.

Authors:  Semih Güder; Şafak Çulfa
Journal:  Dermatol Pract Concept       Date:  2022-07-01

Review 7.  Inflammatory dermatoses in human immunodeficiency virus.

Authors:  Taru Garg; Sarita Sanke
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jul-Dec

8.  Facial Seborrheic Dermatitis in HIV-Seropositive Patients: Evaluation of the Efficacy and Safety of a Non-Steroidal Cream Containing Piroctone Olamine, Biosaccharide Gum-2 and Stearyl Glycyrrhetinate - A Case Series.

Authors:  Carolina Cortés-Correa; Jaime Piquero-Casals; Daniela Chaparro-Reyes; Aurora Garré Contreras; Corinne Granger; Elkin Peñaranda-Contreras
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.